Susquehanna Portfolio Strategies, LLC
Position in PSNL — Personalis, Inc.
CIK 1996449
Bala Cynwyd, PA
Position in PSNL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$390,430
-$101,848 QoQ
Shares Held
61,292
-0.9% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Susquehanna Portfolio Strategies, LLC holds $74,877,691 across 9 Diagnostics & Research names. PSNL ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
360,498 | $41,089,562 | |
| 2 | ILMN |
Illumina, Inc.
|
104,441 | $12,873,397 | |
| 3 | GH |
Guardant Health, Inc.
|
108,479 | $10,020,205 | |
| 4 | DGX |
Quest Diagnostics Inc
|
32,993 | $6,465,968 | |
| 5 | MYGN |
Myriad Genetics Inc
|
364,154 | $1,638,693 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
374,269 | $1,298,713 | |
| 7 | GRAL |
GRAIL, Inc.
|
12,420 | $641,865 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
28,859 | $458,858 |
All Filings in PSNL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $390,430 | 61,292 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $492,278 | 61,844 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $403,222 | 61,844 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $314,512 | 47,944 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $75,156 | 21,412 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||